Objects
Lizak, Nathaniel, Hodgkinson, Suzanne, Butler, Ernest, Lechner-Scott, Jeannette, Slee, Mark, McCombe, Pamela Ann, Shaw, Cameron, Skibina, Olga, Vucic, Steve, Shuey, Neil, Barnett, Michael H., Parratt, John, Butzkueven, Helmut, Jack, Dominic, Fabris, Jessica, Kalincik, Tomas. Sage; 2021. Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: an MSBase registry substudy.
Diouf, Ibrahima, Malpas, Charles B., Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, Roos, Izanne, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Horakova, Dana, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Havrdova, Eva Kubala, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Patti, Francesco, Sinnige, LGF, Sanchez-Menoyo, JL, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Trivino, T, Gray, O, Shaygannejad, Vahid, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Ozakbas, Serkan, Moore, F, Kalincik, T, Izquierdo, Guillermo. Wiley-Blackwell; 2023. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Tao, Chunrong, Simpson, Steve, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Grammond, Pierre, Alroughani, Raed, Terzi, Murat, Oreja-Guevara, Celia, Sajedi, Seyed Aidin, Iuliano, Gerardo, Sola, Patrizia, van der Mei, Ingrid, Lechner-Scott, Jeannette, Van Pesch, Vincent, Pucci, Eugenio, Bergamaschi, Roberto, Barnett, Michael, Ramo, Cristina, Singhal, Bhim, Spitaleri, Daniele L. A., Slee, Mark, Verheul, Freek, Blizzard, Leigh, Fernández Bolaños, Ricardo, Amato, Maria Pia, Cristiano, Edgardo, Granella, Franco, Hodgkinson, Suzanne, Fiol, Marcela, Gray, Orla, McCombe, Pamela, Saladino, Maria Laura, Sánchez Menoyo, José Luis, Havrdova, Eva, Shuey, Neil, Vucic, Steve, Shaw, Cameron, Deri, Norma, Arruda, Walter Oleschko, Butzkueven, Helmut, Spelman, Tim, Taylor, Bruce V., Horakova, Dana, Shaygannejad, Vahid, Lugaresi, Alessandra, Izquierdo, Guillermo, Trojano, Maria. BMJ Group; 2016. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2014. Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
Sanders, Katherine A., Benton, Miles C., Lea, Rod A., Maltby, Vicki E., Agland, Susan, Griffin, Nathan, Scott, Rodney J., Tajouri, Lotto, Lechner-Scott, Jeannette. BioMed Central; 2016. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+T cells.
Warrender-Sparkes, Matthew, Spelman, Tim, Alroughani, Raed, Iuliano, Gerardo, Duquette, Pierre, Girard, Marc, Terzi, Murat, Hupperts, Raymond, Grammond, Pierre, Petersen, Thor, Fernandez-Bolaños, Ricardo, Fiol, Marcela, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Trojano, Maria, Lugaresi, Alessandra, Grand'Maison, François, Havrdova, Eva, Horakova, Dana, Boz, Cavit, Oreja-Guevara, Celia. Sage; 2016. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Kunchok, Amy, Lechner-Scott, Jeannette, Izquierdo, Guillermo, Grammond, Pierre, Luis Sanchez-Menoyo, Jose, Van Wijmeersch, Bart, Boz, Cavit, Pucci, Eugenio, McCombe, Pamela, Grand'Maison, Francois, Spitaleri, Daniele, Vucic, Steve, Granella, Franco, Hupperts, Raymond, Jokubaitis, V, Sormani, MP, Butzkueven, H, Kalincik, T, Trojano, Maria, Alroughani, Raed, Sola, Patrizia, Ferraro, Diana, Lugaresi, Alessandra, Onofrj, Marco, Ozakbas, Serkan. Sage; 2020. Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score.
Afzal, H. M. Rehan, Luo, Suhuai, Ramadan, Saadallah, Lechner-Scott, Jeannette, Li, Jiaming. ACM Press; 2018. Automatic prediction of the conversion of clinically isolated syndrome to multiple sclerosis using deep learning.
Groen, Kira, Maltby, Vicki E., Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. Elsevier; 2020. Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls.
Zhong, Michael, van der Walt, Anneke, Butler, Ernest, Prevost, Julie, Girard, Marc, Oh, Jiwon, Butzkueven, Helmut, Jokubaitis, Vilija, Monif, Mastura, Hodgkinson, Suzanne, Eichau, Sara, Kalincik, Tomas, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Van Pesch, Vincent. Sage Publications; 2023. Prediction of relapse activity when switching to cladribine for multiple sclerosis.
Daruwalla, Cyrus, Shaygannejad, Vahid, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J., Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, Skibina, Olga, Ozakbas, Serkan, Buzzard, Katherine, Grammond, P, Karabudak, R, van der Walt, A, Butzkueven, H, Maimone, D, Lechner-Scott, Jeannette, Soysal, A, John, N, Prevost, J, Havrdova, Eva Kubala, Spitaleri, D, Ramo-Tello, C, Gerlach, O, Iuliano, G, Foschi, M, Ampapa, R, van Pesch, V, Barnett, M, Shalaby, N, D'hooghe, M, Horakova, Dana, Kuhle, J, Sa, MJ, Fabis-Pedrini, M, Kermode, A, Mrabet, S, Gouider, R, Hodgkinson, S, Laureys, G, Van Hijfte, L, Macdonell, R, Alroughani, Raed, Oreja-Guevara, C, Cristiano, E, McCombe, P, Sanchez-Menoyo, JL, Singhal, B, Blanco, Y, Hughes, S, Garber, J, Solaro, C, McGuigan, C, Boz, Cavit, Taylor, B, de Gans, K, Habek, M, Al-Asmi, A, Mihaela, S, Castillo Triviño, T, Al-Harbi, T, Rojas, JI, Gray, O, Khurana, D, Patti, Francesco, Van Wijmeersch, B, Grigoriadis, N, Inshasi, J, Oh, J, Aguera-Morales, E, Fragoso, Y, Moore, F, Shaw, C, Baghbanian, SM, Shuey, N, Onofrj, Marco, Willekens, B, Hardy, TA, Decoo, D, Sempere, AP, Field, D, Wynford-Thomas, R, Cunniffe, NG, Roos, I, Malpas, CB, Coles, AJ, Lugaresi, Alessandra, Kalincik, T, Brown, JWL. Sage; 2023. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Ribbons, Karen, Lea, Rodney, Schofield, Peter W., Lechner-Scott, Jeannette. American Psychiatric Publishing; 2017. Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort.
Odenthal, Cara, Simpson Jr, Steve, Coulthard, Alan, Ausimmune AusLong Investigator Groups,, Williams, David, Lechner-Scott, Jeannette, , , , , , , Oughton, Justin, , , van der Mei, Ingrid, Rose, Stephen, Fripp, Jurgen, Lucas, Robyn, Taylor, Bruce, Dear, Keith, Ponsonby, Anne-Louise. Wiley-Blackwell; 2017. Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: a multicentre Australian cohort study.
Spelman, Tim, Gray, Orla, Boz, Cavit, Verheul, Freek, Oreja-Guevara, Celia, Barnett, Michael, Grand'Maison, Francois, Rio, Maria Edite, Lechner-Scott, Jeannette, Van Pesch, Vincent, Bolanos, Ricardo Fernandez, Flechter, Shlomo, Trojano, Maria, Braber-Moerland, Leontien Den, Iuliano, Gerardo, Amato, Maria Pia, Slee, Mark, Cristiano, Edgardo, Saladino, Maria Laura, Paine, Mark, Vella, Norbert, Kasa, Krisztian, Deri, N, Petersen, Thor, Herbert, Joseph, Moore, Fraser, Petkovska-Boskova, Tatjana, Alroughani, Raed, Savino, Aldo, Shaw, Cameron, Vucic, Steve, Santiago, Vetere, Bacile, Elizabeth Alejandra, Skromne, Eli, Izquierdo, Guillermo, Poehlau, Dieter, Cabrera-Gomez, Jose Antonio, Lucas, Robyn, Butzkueven, Helmut, Lugaresi, Alessandra, Hupperts, Raymond, Bergamaschi, Roberto, Duquette, Pierre, Giuliani, Giorgio. John Wiley and Sons; 2014. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Jokubaitis, Vilija G., Spelman, Tim, Grammond, Pierre, Van Pesch, Vincent, Pucci, Eugenio, Grand'Maison, François, Hupperts, Raymond, Granella, Franco, Sola, Patrizia, Bergamaschi, Roberto, Iuliano, Gerardo, Spitaleri, Daniele, Kalincik, Tomas, Lechner-Scott, Jeannette, Lorscheider, Johannes, Havrdova, Eva, Horakova, Dana, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Izquierdo, Guillermo. John Wiley & Sons; 2016. Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Bahlo, Melanie, Booth, David R., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M.. Nature Publishing Group; 2009. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.
Al-iedani, Oun, Lechner-Scott, Jeannette, Ribbons, Karen, Ramadan, Saadallah. BioMed Central; 2017. Fast magnetic resonance spectroscopic imaging techniques in human brain-applications in multiple sclerosis.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy.
He, Anna, Spelman, Tim, Jokubaitis, Vilija, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Iuliano, Gerardo, Alroughani, Raed, Oreja-Guevara, Cekia, Fernandez-Bolaños, Ricardo, Grand'Maison, Francois, Sola, Patrizia, Spitaleri, Daniele, Granella, Franco, Lechner-Scott, Jeannette. American Medical Association; 2015. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.
MacDonell, Richard, Nagels, Guy, Wang, Ping, Yeh, Michael, Hovenden, Maria, Soelberg Sørensen, Per, Laplaud, David-Axel, Pozzilli, Carlo, de Jong, Brigit, Martins da Silva, Ana, Nicholas, Richard, Lechner-Scott, Jeannette, Gaebler, Julia A., Agarwal, Sonalee. Sage; 2016. Improved patient-reported health impact of multiple sclerosis: the ENABLE study of PR-fampridine.
Groen, Kira, Maltby, Vicki E., Sanders, Katherine A., Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. Sage; 2016. Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology?.
ARM, Jameen, Ribbons, Karen, Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2019. Evaluation of MS related central fatigue using MR neuroimaging methods: scoping review.
Kister, Ilya, Spelman, Tim, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut, , Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre. B M J Group; 2016. Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
Bateman, Grant A., Lechner-Scott, Jeannette, Lea, Rodney A.. BioMed Central; 2016. A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?.
Alshehri, Abdulaziz, Al-iedani, Oun, Koussis, Nikitas, Khormi, Ibrahim, Lea, Rodney, Lechner-Scott, Jeannette, Ramadan, Saadallah. Sage; 2023. Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate.
Bateman, Grant Alexander, Lechner-Scott, Jeannette, Carey, Michael Fionn, Bateman, Alexander Robert, Lea, Rodney Arthur. Elsevier; 2021. Possible Markers of Venous Sinus Pressure Elevation in Multiple Sclerosis: Correlations with Gender and Disease Progression.
Pan, Gongbu, Simpson, Steve, Williams, David, Lechner-Scott, Jeannette, Van Der Mei, Ingrid, Charlesworth, Jac C., Lucas, Robyn, Ponsonby, Anne-Louise, Zhou, Yuan, Taylor, Bruce V.. BMJ Group; 2016. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Bateman, Grant Alexander, Lechner-Scott, Jeannette, Bateman, Alexander Robert, Attia, John, Lea, Rodney Arthur. Elsevier; 2020. The incidence of transverse sinus stenosis in multiple sclerosis: further evidence of pulse wave encephalopathy.
Hughes, Stella E., Spelman, Tim, Grammond, Pierre, Oreja-Guevara, Celia, Hupperts, Raymond, Bergamaschi, Roberto, Giuliani, Giorgio, Lechner-Scott, Jeannette, Barnett, Michael, Edite Rio, Maria, Van Pesch, Vincent, Amato, Maria Pia, Gray, Orla M., Iuliano, Gerardo, Slee, Mark, Verheul, Freek, Cristiano, Edgardo, Fernández-Bolaños, Ricardo, Poehlau, Dieter, Saladino, Maria Laura, Deri, Norma, Cabrera-Gomez, Jose, Vella, Norbert, Boz, Cavit, Herbert, Joseph, Skromne, Eli, Savino, Aldo, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Petkovska-Boskova, Tatjana, McDonnell, Gavin, Hawkins, Stanley, Kee, Frank, Trojano, Maria, Butzkueven, Helmut, Lugaresi, Alessandra, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois. Sage; 2014. Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Kalincik, Tomas, Manouchehrinia, Ali, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Hupperts, Raymond, Grand'Maison, Francois, Pucci, Eugenio, Boz, Cavit, Alroughani, Raed, Sobisek, Lukas, Lechner-Scott, Jeannette, , , , , , , , , , Jokubaitis, Vilija, , , , , , , , , , , Spelman, Tim, , , , , , , , Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra. Oxford University Press; 2017. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Arm, Jameen, Oeltzschner, Georg, Al-iedani, Oun, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2021. Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue.
Roos, Izanne, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Sharmin, Sifat, Ferraro, Diana, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamou, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Horakova, Dana, Maimone, D, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, MJ, Solaro, C, Havrdova, Eva Kubala, Ramo-Tello, C, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, Patti, Francesco, van der Walt, A, Butzkueven, H, Prevost, J, Sanchez-Menoyo, JL, Laureys, G, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaygannejad, Vahid, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Moore, F, Malpas, C, Ozakbas, Serkan, Kalincik, T, Izquierdo, Guillermo, Eichau, Sara. Sage Publications Ltd.; 2023. Comparative effectiveness in multiple sclerosis: A methodological comparison.
Kalincik, Tomas, Kister, Ilya, Ozakbas, Serkan, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Alroughani, Raed, Bacon, Tamar E., Terzi, Murat, Boz, C, Grand'Maison, F, Bergamaschi, R, Gerlach, O, Sa, MJ, Kappos, L, Cartechini, E, Lechner-Scott, Jeannette, van Pesch, V, Malpas, Charles B., Shaygannejad, V, Granella, F, Spitaleri, D, Iuliano, G, Maimone, D, Prevost, J, Soysal, A, Turkoglu, R, Ampapa, R, Butzkueven, H, Sharmin, Sifat, Cutter, G, for MSBase Study Group,, Horakova, Dana, Kubala-Havrdova, Eva, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara. Sage; 2022. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Nguyen, Ai-Lan, Havrdova, Eva Kubala, Horakova, Dana, Izquierdo, Guillermo, Kalincik, Tomas, van der Walt, Anneke, Terzi, Murat, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Boz, Cavit, Sola, Patrizia, Ferraro, Dianna, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Barnett, Michael, Grand'Maison, Francois, Grammond, Pierre, Ramo-Tello, Cristina, Turkoglu, R, McCombe, P, Pucci, E, Trojano, M, Granella, F, Spitaleri, D, Van Pesch, V, Soysal, A, Oreja-Guevara, C, Verheul, F, Vucic, S, Hodgkinson, S, Slee, M, Ampapa, R, Prevost, J, Menoyo, JLS, Skibina, O, Solaro, C, Olascoaga, J, Shaw, C, Madsen, KG, Naidoo, K, Hyde, R, Butzkueven, H, Jokubaitis, V. Elsevier; 2019. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study.
Bukhari, Wajih, Clarke, Laura, Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Chen, Celia, O'Gorman, Cullen, Coulthard, Alan, Dale, RC, Das, C, Dear, K, Fabis-Pedrini, MJ, Fulcher, D, Gillis, D, Hawke, S, Heard, R, Henderson, APD, Khalilidehkordi, Elham, Heshmat, S, Hodgkinson, S, Jimenez-Sanchez, S, Kilpatrick, TJ, King, J, Kneebone, C, Kornberg, AJ, Lechner-Scott, Jeannette, Lin, MW, Lynch, C, Arnett, Simon, Macdonnell, RAL, Mason, DF, McCombe, PA, Pereira, J, Pollard, JD, Reddel, SW, Shaw, C, Spies, J, Stankovich, J, Sutton, I, Prain, Kerri M., Vucic, S, Walsh, M, Wong, RC, Yiu, EM, Barnett, MH, Kermode, AG, Marriott, MP, Parratt, J, Slee, M, Taylor, BV, Woodhall, Mark, Willoughby, E, Wilson, RJ, Brilot, F, Vincent, A, Waters, P, Broadley, SA, Silvestrini, Roger, Bundell, Christine S., Ramanathan, Sudarshini. Springer; 2020. The clinical profile of NMOSD in Australia and New Zealand.
Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessndra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette. American Medical Association; 2019. Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis.
Maltby, Vicki E., Graves, Moira C., Lea, Rodney A., Benton, Miles C., Sanders, Katherine A., Tajouri, Lotti, Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2015. Genome-wide DNA methylation profiling of CD8+T cells shows a distinct epigenetic signature to CD4+T cells in multiple sclerosis patients.
Le, Minh, Malpas, Charles, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Larochelle, Catherine, Alroughani, Raed, Bergamaschi, Roberto, Sola, Patrizia, Ferraro, Diana, Grammond, Pierre, Grand’ Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Boz, C, Hupperts, R, Butzkueven, H, Pucci, E, Granella, F, Van Pesch, V, Soysal, A, Yamout, BI, Lechner-Scott, J, Horáková, Dana, Spitaleri, DLA, Ampapa, R, Turkoglu, R, Iuliano, G, Ramo-Tello, C, Sanchez-Menoyo, JL, Sidhom, Y, Gouider, R, Shaygannejad, V, Prevost, J, Havrdova, Eva, Altintas, A, Fragoso, YD, McCombe, PA, Petersen, T, Slee, M, Barnett, MH, Vucic, S, Van Der Walt, A, Kalincik, T, Trojano, Maria, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Lugaresi, Alessandra. Sage Publications; 2021. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies.
Ma, Gerry Z. M., Stankovich, Jim, Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Danoy, Patrick, Foote, Simon J., Griffiths, Lyn, Heard, Robert N., Kermode, Allan G., Lechner-Scott, Jeannette, Moscato, Pablo, Kilpatrick, Trevor J., Perreau, Victoria M., Scott, Rodney J., Slee, Mark, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Stankovich, Jim, Binder, Michele D., Field, Judith, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L.. Public Library of Science; 2011. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
Vitkova, Marianna, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Larochelle, Catherine, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Malpas, Charles, Sola, Patrizia, Ferraro, D, Grammond, P, Butzkueven, H, Buzzard, K, Skibina, O, Yamout, BI, Karabudak, R, Gerlach, O, Lechner-Scott, Jeannette, Horakova, Dana, Maimone, D, Bergamaschi, R, Van Pesch, V, Iuliano, G, Cartechini, E, José Sà, M, Ampapa, R, Barnett, M, Hughes, SE, Ramo-Tello, CM, Kubala Havrdova, Eva, Hodgkinson, S, Spitaleri, DLA, Petersen, T, Butler, EG, Slee, M, McGuigan, C, McCombe, PA, Granella, F, Cristiano, E, Prevost, J, Patti, Francesco, Taylor, BV, Sãnchez-Menoyo, JL, Laureys, G, Van Hijfte, L, Vucic, S, Macdonell, RA, Gray, O, Olascoaga, J, Deri, N, Fragoso, YD, Ozakbas, Serkan, Shaw, C, Kalincik, T, MSBase Study Group,, Izquierdo, Guillermo, Eichau, Sara, Shaygannejad, Vahid. Wolters Kluwer Health; 2022. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
Spelman, Timothy, Kalincik, Tomas, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Zhang, Annie, Trojano, Maria, Butzkueven, Helmut, , Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek. John Wiley & Sons; 2015. Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2013. Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Groen, Kira, Lea, Rodney A., Maltby, Vicki E., Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2018. Letter to the editor: blood processing and sample storage have negligible effects on methylation.
Hughes, Stella, Spelman, Timothy, Hupperts, Raymond, Boz, Cavit, Bergamaschi, Roberto, Giuliani, Giorgio, Rio, Maria Edite, Lechner-Scott, Jeannette, Van Pesch, Vincent, Iuliano, Gerardo, Fiol, Marcela, Verheul, Freek, Trojano, Maria, , , , , , , , , , , Lugaresi, Alessandra, , , , , Izquierdo, Guillermo, Grand'Maison, Francois, Duquette, Pierre, Girard, Marc, Grammond, Pierre, Oreja-Guevara, Celia. BMJ Group; 2012. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
Lechner-Scott, Jeannette, Reeves, Penny, Ribbons, Karen, Saugbjerg, Bente, Lea, Rodney. CSIRO; 2021. Do people with multiple sclerosis receive appropriate support from the National Disability Insurance Scheme matching their level of disability? A description of disease 'burden and societal cost in people with multiple sclerosis in Australia' (BAC-MS).
Kalincik, Tomas, Jokubaitis, Vilija, Grand'Maison, Francois, Pucci, Eugenio, Van Pesch, Vincent, Boz, Cavit, Iuliano, Gerardo, Fernandez-Bolanos, Ricardo, Flechter, Shlomo, Spitaleri, Daniele, Cristiano, Edgardo, Verheul, Ferek, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Amato, Maria Pia, Cabrera-Gomez, Jose Antonio, Saladino, Maria Laura, Slee, Mark, Moore, Fraser, Gray, Orla, Paine, Mark, Barnett, Michael, Havrdova, Eva, Duquette, Pierre, Horakova, Dana, Spelman, Timothy, Trojano, Maria, Butzkueven, Helmut, , , Girard, Marc, Grammond, Pierre, Lugaresi, Alessandra, Oreja-Guevara, Celia, Bergamaschi, Roberto, Hupperts, Raymond. Sage; 2014. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Brochet, Bruno, Hupperts, Raymond, Langdon, Dawn, Solari, Alessandra, Piehl, Fredrik, Lechner-Scott, Jeannette, Montalban, Xavier, Selmaj, Krzysztof, Valis, Martin, Rejdak, Konrad, Havrdova, Eva K., Patti, Francesco, Alexandri, Nektaria, Nolting, Axel, Keller, Birgit. Elsevier; 2022. Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis.
Riveros, Carlos, Mellor, Drew, Vucic, Stephen, Stewart, Graeme J., Williams, David W., Scott, Rodney J., Lechner-Scott, Jeannette, Booth, David R., Moscato, Pablo, ANZgene Multiple Sclerosis Genetics Consortium, Gandhi, Kaushal S., McKay, Fiona C., Cox, Mathew B., Berretta, Regina, Vaezpour, S. Yahya, Inostroza-Ponta, Mario, Broadley, Simon A., Heard, Robert N.. Public Library of Science; 2010. A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.
Yan, Jun, Liu, Jia, Mason, Deborah, Griffiths, Lyn, Moscato, Pablo, Slee, Mark, Taylor, Bruce, Wiley, James, Field, Judith, Butzkueven, Helmut, Kilpatrick, Trevor J., Csurhes, Peter A., Lin, Clement Yihao, Pender, Michael P., McCombe, Pamela A., Greer, Judith M., Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZGene),, Scott, Rodney J., Lechner-Scott, Jeannette, Brown, Matthew A., Booth, David R., Stewart, Graeme J., Broadley, Simon. MDPIAG; 2012. Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
Al-iedani, Oun, Arm, Jameen, Ribbons, Karen, Lea, Rodney L., Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2018. Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.
Maltby, Vicki E., Lea, Rodney A., Sanders, Katherine A., White, Nicole, Benton, Miles C., Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2017. Differential methylation at MHC in CD4⁺ T cells is associated with multiple sclerosis independently of HLA-DRB1.
Giovannoni, Gavin, Hawkes, Christopher H., Lechner-Scott, Jeannette, Levy, Michael, Yeh, E. Ann. Elsevier; 2023. Is it ethical to use teriflunomide as an active comparator in phase 3 trials?.
Roos, Izanne, Leray, Emmanuelle, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Frascoli, Federico, Sá, Maria José, Cartechini, E, Boz, C, Granella, F, Hupperts, R, Terzi, M, Lechner-Scott, Jeannette, Spitaleri, D, Van Pesch, V, Soysal, A, Casey, Romain, Olascoaga, J, Prevost, J, Aguera-Morales, E, Slee, M, Csepany, T, Turkoglu, R, Sidhom, Y, Gouider, R, Van Wijmeersch, B, McCombe, P, Brown, J. William L., Macdonell, R, Coles, A, Malpas, CB, Butzkueven, H, Vukusic, S, Kalincik, T, , , Horakova, Dana, Havrdova, Eva K., Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo. Oxford University Press; 2020. Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Cox, Mathew B., Cairns, Murray J., ANZgene Multiple Sclerosis Genetics Consortium, Gandhi, Kaushal S., Carroll, Adam P., Moscovis, Sophia, Stewart, Graeme J., Broadley, Simon, Scott, Rodney J., Booth, David R., Lechner-Scott, Jeannette. Public Library of Science; 2010. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.
Cox, Mathew B., Ban, Maria, Bowden, Nikola A., Baker, Amie, Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2012. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian. Elsevier; 2020. The COVID-19 pandemic and the use of MS disease-modifying therapies.
Clarke, Laura, Arnett, Simon, Bundell, Christine S., Abernethy, David A., Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Bukhari, Wajih, Chen, Cella, Coulthard, A, Dale, RC, Das, C, Fabis-Pedrini, MJ, Gillis, D, Hawke, S, Heard, R, Henderson, APD, Heshmat, S, Khalilidehkordi, Elham, Hodgkinson, S, Kilpatrick, TJ, King, J, Kneebone, C, Kornberg, AJ, Lechner-Scott, Jeannette, Lin, M-W, Lynch, C, Macdonell, RAL, Mason, DF, Sanchez, Sofia Jimenez, McCombe, PA, Pereira, J, Pollard, JD, Ramanathan, S, Reddel, SW, Shaw, CP, Spies, JM, Stankovich, J, Sutton, I, Vucic, S, O'Gorman, Cullen, Walsh, M, Wong, RC, Yiu, EM, Barnett, MH, Kermode, AGK, Marriott, MP, Parratt, JDE, Slee, M, Taylor, B, Willoughby, E, Sun, Jing, Brilot, F, Vincent, A, Waters, P, Broadley, SA, Prain, Kerri M., Woodhall, Mark, Silvestrini, Roger. Frontiers Research Foundation; 2021. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Burnard, Sean, Lechner-Scott, Jeannette, Scott, Rodney J.. Elsevier; 2017. EBV and MS: major cause, minor contribution or red-herring?.
Groen, Kira, Maltby, Vicki E., Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. John Wiley & Sons; 2020. Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes.
Shahijanian, Fernando, Parnell, Grant P., Baxter, Alan, Kermode, Allan, Carroll, William, Butzkueven, Helmut, Booth, David, Stewart, Graeme, Vucic, Steve, Wiley, James, Field, Judith, Tajouri, Lotti, McKay, Fiona C., Griffiths, Lyn, Barnett, Michael, Scott, Rodney, Lechner-Scott, Jeannette, Moscato, Pablo, Broadley, Simon, Slee, Mark, Kilpatrick, Trevor, Taylor, Bruce, Charlesworth, Jac, Gatt, Prudence N., Brown, Matt, Mason, Deborah, Stewart, Graeme J., Booth, David R., Shojoei, Maryam, O'Connor, Kate S., Schibeci, Stephen D., Brilot, Fabienne, Liddle, Christopher, Batten, Marcel. Oxford University Press; 2014. The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations.
Ahmad, Hasnat, van der Mei, Ingrid, Palmer, Andrew J., Taylor, Bruce V., Lucas, Robyn M., Ponsonby, Anne-Louise, Lechner-Scott, Jeannette, Dear, Keith, Valery, Patricia, Clarke, Philip M., Simpson, Steve. Sage; 2019. Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis.
Bukhari, Wajih, Prain, Kerri M., Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Waters, Patrick, Dale, Russell C., Woodhall, Mark, Lechner-Scott, Jeannette, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep. BMJ Group; 2017. Incidence and prevalence of NMOSD in Australia and New Zealand.
Rhead, Brooke, Brorson, Ina S., Lea, Rodney A., Burnard, Sean, Maltby, Vicki E., Scott, Rodney J., Lechner-Scott, Jeannette, Harbo, Hanne F., Bos, Steffan D., Barcellos, Lisa F., Berge, Tone, Adams, Cameron, Quach, Hong, Moen, Stine Marit, Berg-Hansen, Pål, Celius, Elizabeth Gulowsen, Sangurdekar, Dipen P., Bronson, Paola G.. Public Library of Science; 2018. Increased DNA methylation of SLFN12 in CD4⁺ and CD8⁺ T cells from multiple sclerosis patients.
Bateman, Grant A., Bateman, Alexander R., Lechner-Scott, Jeannette. Elsevier; 2023. Dilatation of the bridging cerebral veins in multiple sclerosis correlates with fatigue and suggests an increase in pressure.
Jokubaitis, Vilija G., Spelman, Tim, Cabrera-Gomez, José, Oreja-Guevara, Celia, Boz, Cavit, Giuliani, Giorgio, Fernández-Bolaños, Ricardo, Iuliano, Gerardo, Lechner-Scott, Jeannette, Verheul, Freek, van Pesch, Vincent, Petkovska-Boskova, Tatjana, Kalincik, Tomas, Fiol, Marcela, Moore, Fraser, Cristiano, Edgardo, Alroughani, Raed, Bergamaschi, Roberto, Barnett, Michael, Slee, Mark, Vella, Norbet, Herbert, Joseph, Shaw, Cameron, Izquierdo, Guillermo, Saladino, Maria Laura, Amato, Maria Pia, Liew, Danny, Paolicelli, Damiano, Butzkueven, Helmut, Trojano, Maria, Grand'Maison, François, Duquette, Pierre, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Hupperts, Raymond. John Wiley & Sons; 2015. Predictors of disability worsening in clinically isolated syndrome.
Schofield, Peter W., Lechner-Scott, Jeannette, Loughland, Carmel, Moore, Tammie. Nova Science Publishers; 2013. The Audio Recorded Cognitive Screen (ARCS): a flexible and versatile instrument for clinic or research.
Fambiatos, Adam, Jokubaitis, Vilija, Grand'Maison, Francois, Grammond, Pierre, Sola, Patricia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Hupperts, Raymond, Boz, Cavit, Lechner-Scott, Jeannette, Pucci, Eugenio, Horakova, Dana, Bergamaschi, Roberto, Van Pesch, V, Ozakbas, S, Granella, F, Turkoglu, R, Iuliano, G, Spitaleri, D, McCombe, P, Solaro, C, Slee, M, Kubala Havrdova, Eva Kubala, Ampapa, R, Soysal, A, Petersen, T, Sanchez-Menoyo, JL, Verheul, F, Prevost, J, Sidhom, Y, Van Wijmeersch, B, Vucic, S, Cristiano, E, Trojano, Maria, Saladino, ML, Deri, N, Barnett, M, Olascoaga, J, Moore, F, Skibina, O, Gray, O, Fragoso, Y, Yamout, B, Shaw, C, Prat, Alexandre, Singhal, B, Shuey, N, Hodgkinson, S, Altintas, A, Al-Harbi, T, Csepany, T, Taylor, B, Hughes, J, Jun, J-K, van der Walt, A, Girard, Marc, Spelman, T, Butzkueven, H, Kalincik, T, Duquette, Pierre, Lugaresi, Alessandra, Izquierdo, Guillermo. Sage; 2020. Risk of secondary progressive multiple sclerosis: a longitudinal study.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Australasian Medical Publishing Company Pty. Ltd.; 2015. A new era in the treatment of multiple sclerosis.
Kalincik, Thomas, Cutter, Gary, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Spelman, Tim, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Jokubaitis, Vilija, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre. Oxford University Press; 2015. Defining reliable disability outcomes in multiple sclerosis.
Harding-Forrester, Sam, Roos, Izanne, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ozakbas, Serkan, Nguyen, Ai-Lan, Amato, Maria Pia, Gerlach, O, Sola, P, Ferraro, D, Buzzard, K, Skibina, O, Lechner-Scott, Jeannette, Alroughani, R, Boz, C, Van Pesch, V, Malpas, Charles B., Cartechini, E, Terzi, M, Maimone, D, Ramo-Tello, C, Yamout, B, Khoury, SJ, La Spitaleri, D, Sa, MJ, Blanco, Y, Granella, F, Diouf, Ibrahima, Slee, M, Butler, E, Sidhom, Y, Gouider, R, Bergamaschi, R, Karabudak, R, Ampapa, R, Sanchez-Menoyo, JL, Prevost, J, Castillo-Trivino, T, Moradi, Nahid, McCombe, PA, Macdonell, R, Laureys, G, Van Hijfte, L, Oh, J, Altintas, A, de Gans, K, Turkoglu, R, van der Walt, A, Butzkueven, H, Sharmin, Sifat, Vucic, S, Barnett, M, Cristiano, E, Hodgkinson, S, Iuliano, G, Kappos, L, Kuhle, J, Shaygannejad, V, Soysal, A, Weinstock-Guttman, B, Izquierdo, Guillermo, Van Wijmeersch, B, Kalincik, T, Eichau, Sara, Patti, Francesco. BMJ Group; 2023. Disability accrual in primary and secondary progressive multiple sclerosis.
Gandhi, Kaushal S., McKay, Fiona C., Danoy, Patrick, Stewart, Graeme J., Broadley, Simon, Moscato, Pablo, Lechner-Scott, Jeannette, Scott, Rodney J., Booth, David R., ANZgene Multiple Sclerosis Genetics Consortium, Cox, Mathew, Riveros, Carlos, Armstrong, Nicola, Heard, Robert N., Vucic, Steve, Williams, David W., Stankovich, Jim, Brown, Matthhew. Oxford University Press; 2010. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.
Spelman, Tim, Ozakbas, Serkan, Soysal, Aysun, Kuhle, Jens, Sanchez-Menoyo, Jose Luis, Blanco Morgado, Yolanda, Spitaleri, Daniele L. A., van Pesch, Vincent, Horakova, Dana, Ampapa, Radek, Patti, Francesco, Macdonell, Richard, Alroughani, Raed, Al-Asmi, A, Gerlach, O, Oh, J, Altintas, A, Tundia, N, Wong, SL, Butzkueven, H, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Van Der Walt, Anneke, Yamout, Bassem, Lechner-Scott, Jeannette. Sage Publications; 2023. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Badam, Tejaswi V., Hellberg, Sandra, Berg, Göran, Jenmalm, Maria C., Gustafsson, Mika, Ernerudh, Jan, Mehta, Ratnesh B., Lechner-Scott, Jeannette, Lea, Rodney A., Tost, Jorg, Mariette, Xavier, Svensson-Arvelund, Judit, Nestor, Colm E., Benson, Mikael. Taylor & Francis; 2022. CD4+ T-cell DNA methylation changes during pregnancy significantly correlate with disease-associated methylation changes in autoimmune diseases.
Merlo, Daniel, Stankovich, Jim, Darby, David, Butzkueven, Helmut, Van der Walt, Anneke, Bai, Claire, Kalincik, Tomas, Zhu, Chao, Gresle, Melissa, Lechner-Scott, Jeannette, Kilpatrick, Trevor, Barnett, Michael, Taylor, Bruce. Wolters Kluwer Health; 2021. Association between cognitive trajectories and disability progression in patients with relapsing-remitting multiple sclerosis.
Lopez, Joseph A., Houston, Samuel D., Denkova, Martina, Lechner-Scott, Jeannette, van der Walt, Anneke, Barnett, Michael H., Reddel, Stephen W., Broadley, Simon, Ramanathan, Sudarshini, Dale, Russel C., Brown, David A., Brilot, Fabienne, Tea, Fiona, Merheb, Vera, Lee, Fiona X. Z., Smith, Sandy, McDonald, David, Zou, Alicia, Liyanage, Ganesha, Pilli, Deepti. Oxford University Press; 2022. Validation of a Flow Cytometry Live Cell-Based Assay to Detect Myelin Oligodendrocyte Glycoprotein Antibodies for Clinical Diagnostics.
Maltby, Vicki E., Lea, Rodney A., Graves, Moira C., Sanders, Katherine A., Benton, Miles C., Tajouri, Lotti, Scott, Rodney J., Lechner-Scott, Jeannette. Nature Publishing Group; 2018. Genome-wide DNA methylation changes in CD19⁺ B cells from relapsing-remitting multiple sclerosis patients.
Jameen, A. R. M., Al-iedani, Oun, Ribbons, Karen, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. Wiley-Blackwell Publishing; 2021. Biochemical Correlations with Fatigue in Multiple Sclerosis Detected by MR 2D Localized Correlated Spectroscopy.
Clarke, Laura, Bukhari, Wajih, McCombe, Pamela A., Sutton, Ian, Boggild, Mike, Brownlee, Wallace, Carroll, William M., Hodgkinson, Suzanne, Macdonell, Richard A.L., Mason, Deborah F., Pereira, Jennifer, Slee, Mark, O'Gorman, Cullen M., Das, Chandi, Henderson, APD, Kermode, AG, Lechner-Scott, Jeannette, Waters, P, Sun, J, Broadley, SA, Khalilidehkordi, Elham, Arnett, Simon, Woodhall, Mark, Prain, Kerri M., Parratt, John D.E., Barnett, Michael H., Marriott, Mark P.. Elsevier; 2022. Response to treatment in NMOSD: the Australasian experience.
Patsopoulos, Nikolaos A., de Bakker, Paul I. W., Kappos, Ludwig, Miller, David, Montalbán, Javier, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Arnason, Barry G. W., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Esposito, Federica, Goodin, Douglas S., Jeffery, Douglas, O'Connor, Paul, Ebers, George C., Langdon, Dawn, Reder, Anthony T., Traboulsee, Anthony, Zipp, Frauke, Schimrigk, Sebastian, Hillert, Jan, Reischl, Joachim, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Foote, Simon J., Lehr, Stephan, Griffiths, Lyn, Kermode, Allan G., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Heard, Robert N., Pender, Michael P., Perreau, Victoria M., Bauer, David, Perera, Devindri, Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Tubridy, Niall, Willoughby, Ernest, Wiley, James, Heubach, Jürgen, Matthews, Paul, Boneschi, Filippo M., Compston, Alastair, Haines, Jonathan, Hauser, Stephen L., McCauley, Jacob, Ivinson, Adrian, Oksenberg, Jorge R., Pericak-Vance, Margaret, Sawcer, Stephen J., Sandbrink, Rupert, De Jager, Philip L., Hafler, David A., Pohl, Christoph, Edan, Gilles. John Wiley & Sons; 2011. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Sharmin, Sifat, Lefort, Mathilde, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand'Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Andersen, Johanna Balslev, Trojano, Maria, McCombe, P, Slee, M, Lechner-Scott, Jeannette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Leray, Emmanuelle, Skibina, O, Buzzard, K, Van der Walt, A, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Horakova, Dana, Ciron, J, Ruet, A, De Seze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Havrdova, Eva Kubala, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Alroughani, Raed, Montcuquet, A, Wahab, A, Camdessanche, J-P, Maurousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Izquierdo, Guillermo, Laplaud, D, Koch-Henriksen, N, Sellebjerg, FT, Soerensen, PS, Pfleger, CC, Rasmussen, PV, Jensen, MB, Frederiksen, JL, Bramow, S, Mathiesen, HK, Ozakbas, Serkan, Schreiber, KI, Magyari, M, Vukusic, S, Butzkueven, H, Kalincik, T, Patti, Francesco. Adis International; 2021. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Kalincik, Tomas, Jokubaitis, Vilja, Duquette, Pierre, Grammond, Pierre, Solaro, Claudio, Grand'Maison, Francois, Hupperts, Raymond, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Butler, Ernest, Spelman, Tim, Slee, Mark, Kermode, Allan, Fabis-Pedrini, Marzena, McCombe, Pamela, Barnett, Michael, Shaw, Cameron, Hodgkinson, Suzanne, Butzkueven, Helmut, MSBase Study Group,, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc. Sage; 2018. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
Parnell, Grant P., Gatt, Prudence N., Liddle, Christopher, Slee, Mark, Vucic, Steve, Stewart, Graeme J., Booth, David R., McKay, Fiona C., Schibeci, Stephen, Krupa, Malgorzata, Powell, Joseph E., Visscher, Peter M., Montgomery, Grant W., Lechner-Scott, Jeannette, Broadley, Simon. Sage Publications; 2014. Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Groen, Kira, Maltby, Vicki E., Lea, Rodney A., Sanders, Katherine A., Fink, J. Lynn, Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. BioMed Central; 2018. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Cortes, Adrian, Field, Judith, Glazov, Evgeny A., Hadler, Johanna, ANZgene Consortium,, Stankovich, Jim, Brown, Matthew A., Lechner-Scott, Jeannette, Moscato, Pablo. Oxford University Press; 2013. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Campagna, Maria Pia, Xavier, Alexandre, Lechner-Scott, Jeannette, Maltby, Vicky, Scott, Rodney J., Butzkueven, Helmut, Jokubaitis, Vilija G., Lea, Rodney A.. BioMed Central Ltd.; 2021. Epigenome-wide association studies: current knowledge, strategies and recommendations.
Kunchok, Amy, Malpas, Charles, Ozakbas, Serkan, Olascoaga, Javier, Simo, Magdolna, Granella, Franco, Patti, Francesco, McCombe, Pamela, Csepany, Tundle, Singhal, Bhim, Bergamaschi, Roberto, Fragoso, Yara, Nytrova, Petra, Al-Harbi, Talal, Turkoglu, Recai, Lechner-Scott, Jeannette, Laureys, Guy, Oreja-Guevara, Celia, Pucci, Eugenio, Sola, Patrizia, Ferraro, Diana, Altintas, Ayse, Soysala, Aysun, Havrdova, Eva Kubala, Vucic, Steve, Grand'Maison, Francois, Izquierdo, Guillermo, Eichau, Sara, Lugaresi, Alessandra, Onofrj, Marco, Trojano, Maria, Marriott, Mark, Butzkueven, Helmut, Kister, Ilya, Alroughani, Raed, Kalincik, Tomas, Terzi, Murat, Yamout, Bassem, Hor, Jyh Yung, Karabudak, Rana, Boz, Cavit. Elsevier; 2020. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder.
Kalincik, Tomas, Horakova, Dana, Spelman, Tim, Jokubaitis, Vilija, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne. John Wiley & Sons; 2015. Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
Min, Myintzu, Spelman, Tim, Sanchez-Menoyo, Jose Luis, Barnett, Michael, Girard, Marc, Trojano, Maria, Grammond, Pierre, Duquette, Pierre, Sola, Patrizia, Alroughani, Raed, Hupperts, Raymond, Vucic, Steve, Lugaresi, Alessandra, Kalincik, Tomas, Van pesch, Vincent, Lechner-Scott, Jeannette, Boz, Cavit, Spitaleri, Daniele L. A., Pucci, Eugenio, Grand'Maison, Francois, Granella, Franco, Izquierdo, Guillermo, Butzkueven, Helmut. Sage; 2018. Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis.
Peroni, Silvia, Sorosina, Melissa, Álvarez-Cermeño, José Carlos, Guaschino, Clara, Radaelli, Marta, Citterio, Lorena, Lechner-Scott, Jeannette, Spataro, Nino, Navarro, Arcadi, Martinelli, Vittorio, Montalban, Xavier, Weiner, Howard L., Malhotra, Sunny, de Jager, Philip, Comi, G, Esposito, F, Comabella, M, Martinelli-Boneschi, F, Clarelli, Ferdinando, Osiceanu, Ana Maria, Ferrè, Laura, Roostaei, Tina, Rio, Jordi, Midaglia, Luciana, Villar, Luis Maria. Sage; 2020. A pharmacogenetic study implicates NINJ2 in the response to Interferon-ß in multiple sclerosis.
De Brouwer, Edward, Becker, Thijs, Kappos, Ludwig, Sola, Patrizia, Cartechini, Elisabetta, Lechner-Scott, Jeannette, Alroughani, Raed, Gerlach, Oliver, Kalincik, Tomas, Granella, Franco, Grand'Maison, Francois, Bergamaschi, Roberto, Moreau, Yves, José Sá, M, Van Wijmeersch, B, Soysal, A, Sanchez-Menoyo, JL, Solaro, C, Boz, C, Iuliano, G, Buzzard, K, Aguera-Morales, E, Terzi, M, Havrdova, Eva Kubala, Trivio, TC, Spitaleri, D, Van Pesch, V, Shaygannejad, V, Moore, F, Oreja-Guevara, C, Maimone, D, Gouider, R, Csepany, T, Ramo-Tello, C, Trojano, Maria, Peeters, L, Eichau, Sara, Ozakbas, Serkan, Onofrj, Marco, Grammond, Pierre, Kuhle, Jens. Elsevier; 2021. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.
Spelman, Tim, Horakova, Dana, Csepany, Tunde, Boz, Cavit, Lechner-Scott, Jeannette, Granella, Franco, Grand'Maison, Francois, van der Walt, Anneke, Zhu, Chao, Butzkueven, Helmut, Ozakbas, Serkan, Alroughani, Raed, Onofrj, Marco, Kalincik, Tomas, Prat, Alexandre, Terzi, Murat, Grammond, Pierre, Patti, Francesco. Elsevier; 2023. Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity.
Stewart, Tamasine, Spelman, Tim, Grand'Maison, Francois, Grammond, Pierre, Sola, Patrizia, Shaygannejad, Vahid, Hupperts, Raymond, Alroughani, Raed, Oreja-Guevara, Celia, Pucci, Eugenio, Boz, Cavit, Lechner-Scott, Jeannette, Havrdova, Eva, , , , , , , , , , , Horakova, Dana, , , , , , , , , , , Trojano, Maria, , , , , , , , , , , Izquierdo, Guillermo, , , , , , Duquette, Pierre, Girard, Marc, Prat, Alexandre, Lugaresi, Alessandra. Sage; 2017. Contribution of different relapse phenotypes to disability in multiple sclerosis.
Kalincik, Tomas, Brown, J. William L., McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Robertson, Neil, Lechner-Scott, Jeannette, , , , , , , , , , Willis, Mark, , , , , , , , , , , Scolding, Neil, , , , , , , , , , , Rice, Claire M., Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael. Lancet Publishing; 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Arm, Jameen, Al-Iedani, Oun, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. John Wiley & Sons; 2019. Diurnal variability of cerebral metabolites in healthy human brain with two-dimensional localised correlation spectroscopy (2D L-COSY).
Ribbons, Karen, Lea, Rodney, Tiedeman, Clare, Mackenzie, Laura, Lechner-Scott, Jeannette. Sage; 2017. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 50-year study.
Maltby, Vicki E., Lea, Rodney A., Ribbons, Karen, Lea, Marino G., Schofield, Peter W., Lechner-Scott, Jeannette. Elsevier; 2020. Comparison of BICAMS and ARCS for assessment of cognition in multiple sclerosis and predictive value of employment status.
Binder, Michele D., Fox, Andrew D., Laverick, Louise, Foo, Grace, Fabis-Pedrini, Marzena J., Spelman, Timothy, Jordan, Margaret A., Baxter, Alan G., Foote, Simon, , , , Merlo, Daniel, , , , , , , , , , Lechner-Scott, Jeannette, Johnson, Laura J., , , , , , Moscato, Pablo, Scott, Rodney, , , , Giuffrida, Sarah E., , Calvert, Rainer, Akkermann, Rainer, Ma, Gerry Z. M., Perera, Ashwyn A., Gresle, Melissa M.. Public Library of Science (PLoS); 2016. Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status.
Gu, Ben J., Field, Judith, Butzkueven, Helmut, Gresle, Melissa, Laws, Simon M., Petrou, Steven, Hoffjan, Sabine, Akkad, Denis A., Graham, Colin A., Hawkins, Stanley, Glaser, Anna, Bedri, Sahl Khalid, Dutertre, Sébastien, Hillert, Jan, Matute, Carlos, Antiguedad, Alfredo, Wiley, James S., Ou, Amber, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Scott, Rodney, Lea, Rodney, Taylor, Bruce V., Stankovich, Jim. Oxford University Press; 2015. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.